Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementation Evaluation of a Multicomponent Intervention to Address the Infectious Disease and Overdose Syndemic Among People Who Use Drugs in Rural Settings.

Journal of public health management and practice : JPHMP·2026
Same author

Pediatric inpatient influenza vaccination before, during and after the COVID-19 pandemic.

Journal of the Pediatric Infectious Diseases Society·2026
Same author

Evaluation of steroids for acute COVID in the prevention of long COVID in children: An EHR and pediatric cohort study from the RECOVER Initiative.

PloS one·2026
Same author

Tailoring silicone mixtures for soft robotics: predictive modeling and experimental validation in pneumatic soft actuators.

Bioinspiration & biomimetics·2026
Same author

Use of a large language model for surveillance of central line-associated bloodstream infections at a pediatric medical center.

Infection control and hospital epidemiology·2026
Same author

A Simulation-Based, Qualitative Assessment of Decision Making Among Critical Care Transport Crews.

Air medical journal·2026

Related Experiment Video

Updated: Jun 22, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.1K

Design and Pilot Implementation of an ECHO Module on Hepatitis C Virus Infection During Pregnancy.

Lynn M Yee1, Andrew Aronsohn2, Seema K Shah3

  • 1Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Journal of the Pediatric Infectious Diseases Society
|September 13, 2024
PubMed
Summary

A new Project ECHO® module trained prenatal providers on shared decision-making for hepatitis C virus (HCV) treatment during pregnancy. The training increased provider self-efficacy in managing HCV treatment in pregnant patients.

Keywords:
hepatitis C viruspregnancytreatment

More Related Videos

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
09:11

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

20.7K
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.7K

Related Experiment Videos

Last Updated: Jun 22, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.1K
Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
09:11

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

20.7K
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.7K

Area of Science:

  • Hepatology
  • Maternal-Fetal Medicine
  • Medical Education

Background:

  • Hepatitis C virus (HCV) infection in pregnancy presents unique challenges for treatment decisions.
  • Shared decision-making (SDM) is crucial for optimizing patient-centered care in prenatal settings.
  • Effective training is needed to equip healthcare providers with skills for SDM in HCV management during pregnancy.

Purpose of the Study:

  • To develop and evaluate a Project ECHO® module focused on SDM for HCV treatment in pregnant individuals.
  • To assess the impact of the ECHO module on prenatal providers' self-efficacy regarding HCV treatment during pregnancy.

Main Methods:

  • Development of a specialized Project ECHO® module.
  • Pilot implementation of the ECHO module for prenatal care providers.
  • Assessment of participant self-efficacy scores pre- and post-module completion.

Main Results:

  • The ECHO module successfully delivered training on HCV in pregnancy and treatment benefits.
  • Participants demonstrated increased self-efficacy scores after completing the module.
  • The pilot program indicated a positive association between the training and improved provider confidence.

Conclusions:

  • Project ECHO® is an effective platform for delivering specialized training on HCV management in pregnancy.
  • Enhanced provider self-efficacy can facilitate shared decision-making for HCV treatment in prenatal care.
  • This training approach holds promise for improving care for pregnant individuals with HCV.